Kras confers stem-like properties on certain cell types, Kras deletion leads to death during embryogenesis in mice, and it is in pancreatic cancer that the activating Kras mutations are the most frequent [27]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.